SG11202008078QA - Treatment and prevention of pre-eclampsia - Google Patents

Treatment and prevention of pre-eclampsia

Info

Publication number
SG11202008078QA
SG11202008078QA SG11202008078QA SG11202008078QA SG11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA
Authority
SG
Singapore
Prior art keywords
eclampsia
prevention
treatment
Prior art date
Application number
SG11202008078QA
Inventor
Vries Sijmen De
Bruno Giannetti
Original Assignee
Pharming Intellectual Property B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharming Intellectual Property B V filed Critical Pharming Intellectual Property B V
Publication of SG11202008078QA publication Critical patent/SG11202008078QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202008078QA 2018-02-28 2019-02-28 Treatment and prevention of pre-eclampsia SG11202008078QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18159064 2018-02-28
PCT/EP2019/055001 WO2019166556A1 (en) 2018-02-28 2019-02-28 Treatment and prevention of pre-eclampsia

Publications (1)

Publication Number Publication Date
SG11202008078QA true SG11202008078QA (en) 2020-09-29

Family

ID=61521416

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202008078QA SG11202008078QA (en) 2018-02-28 2019-02-28 Treatment and prevention of pre-eclampsia

Country Status (15)

Country Link
US (1) US20200390872A1 (en)
EP (1) EP3758739B1 (en)
JP (1) JP2021515757A (en)
KR (1) KR20210005549A (en)
CN (1) CN111818938A (en)
AU (1) AU2019226355A1 (en)
BR (1) BR112020017626A2 (en)
CA (1) CA3092163A1 (en)
EA (1) EA202092045A1 (en)
IL (1) IL276905A (en)
MA (1) MA52121A (en)
MX (1) MX2020008969A (en)
PH (1) PH12020551331A1 (en)
SG (1) SG11202008078QA (en)
WO (1) WO2019166556A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3895726A1 (en) 2020-04-17 2021-10-20 Pharming Intellectual Property BV Using c1 esterase inhibitor to treat viral infection-related acute respiratory distress
WO2023280981A1 (en) 2021-07-09 2023-01-12 Pharming Intellectual Property B.V. Using c1 esterase inhibitor to treat viral infection-related symptoms

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
GB9618931D0 (en) 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
ATE382635T1 (en) * 2000-01-31 2008-01-15 Pharming Intellectual Pty Bv HUMAN C1 INHIBITOR PRODUCED IN THE MILK OF TRANSGENIC MAMMALS
US7067713B2 (en) * 2000-01-31 2006-06-27 Pharming Intellectual Property B.V. C1 Inhibitor produced in the milk of transgenic non-human mammals
US20050255114A1 (en) * 2003-04-07 2005-11-17 Nuvelo, Inc. Methods and diagnosis for the treatment of preeclampsia
ES2830499T3 (en) 2003-05-16 2021-06-03 Pharming Intellectual Property B V C1 inhibitor with a short half-life for transient treatment
WO2007073186A2 (en) 2005-12-21 2007-06-28 Pharming Intellectual Property Bv Use of c1 inhibitor for the prevention of ischemia-reperfusion injury
CN105641688B (en) * 2005-12-21 2020-06-09 法明知识产权股份有限公司 Use of C1 inhibitor for preventing ischemia-reperfusion injury
EP2912065A4 (en) * 2012-10-25 2016-10-19 True North Therapeutics Inc Anti-complement c1s antibodies and uses thereof
US20150330989A1 (en) * 2012-11-15 2015-11-19 The Brigham And Women's Hospital, Inc. Method and system for diagnosing and treating preeclampsia
CN111529708A (en) 2013-03-15 2020-08-14 夏尔维洛药品公司 C1-INH compositions and methods for the prevention and treatment of disorders associated with a deficiency in C1 esterase inhibitors
WO2016081889A1 (en) * 2014-11-21 2016-05-26 Kurt Baekgaard Osther Recombinant c1 esterase inhibitor and use thereof
MA45473A (en) 2016-04-04 2019-02-13 Shire Human Genetic Therapies CONJUGATE C1 ESTERASE INHIBITOR AND ITS USES
EP3895726A1 (en) * 2020-04-17 2021-10-20 Pharming Intellectual Property BV Using c1 esterase inhibitor to treat viral infection-related acute respiratory distress

Also Published As

Publication number Publication date
EP3758739A1 (en) 2021-01-06
JP2021515757A (en) 2021-06-24
AU2019226355A1 (en) 2020-09-17
MA52121A (en) 2021-06-02
EP3758739B1 (en) 2024-05-15
US20200390872A1 (en) 2020-12-17
MX2020008969A (en) 2021-02-16
EA202092045A1 (en) 2020-11-09
KR20210005549A (en) 2021-01-14
WO2019166556A1 (en) 2019-09-06
CA3092163A1 (en) 2019-09-06
BR112020017626A2 (en) 2020-12-22
IL276905A (en) 2020-10-29
PH12020551331A1 (en) 2021-09-06
CN111818938A (en) 2020-10-23

Similar Documents

Publication Publication Date Title
IL277648A (en) Therapeutic microbiota for the treatment and/or prevention of food allergy
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
GB201804514D0 (en) Treatment of pyroptosis
EP3706736A4 (en) Ash1l degraders and methods of treatment therewith
IL263368A (en) Prevention and treatment of viral infections
GB201804515D0 (en) Treatment of necroptosis
IL275925A (en) Prevention and treatment of organ fibrosis
ZA202000558B (en) Prevention and/or treatment of neurodegenerative disease
IL276905A (en) Treatment and prevention of pre-eclampsia
GB201616009D0 (en) Treatment and/or prevention of sepsis
ZA202002669B (en) Prevention and treatment of graft-versus-host-disease with defensins
EP3599983A4 (en) Endoscopes and methods of treatment
ZA201906964B (en) Prevention and/or treatment of inflammatory skin disease
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
PT3624812T (en) Methods and treatment of trauma
EP3525771A4 (en) Prevention and/or treatment of contrast-induced acute kidney injury
IL268860A (en) Granzyme b inhibitor compositions and methods for the prevention and/or treatment of skin blistering and/or peeling
GB201810923D0 (en) Compositions and method of treatment
IL256675A (en) Methods and compositions for prevention and treatment of pressure ulcers
GB201815000D0 (en) Treatment of hypothroidism and related conditions
GB201815694D0 (en) Prevention and treatment of cancer
GB201809946D0 (en) Prevention and treatment of cancer
GB2603379B (en) Avocatin B for the treatment of diseases and conditions
SG11202009295YA (en) Treatment and prophylaxis of amyloidosis
IL282686A (en) Treatment and prevention of premature ejaculation (pe)